{
    "clinical_study": {
        "@rank": "33449", 
        "arm_group": {
            "arm_group_label": "All patients"
        }, 
        "brief_summary": {
            "textblock": "This study is conducted in Europe. The purpose of the study (Diabetes Pregnancy Registry) is\n      to evaluate the safety of treatment with insulin detemir in pregnant women with diabetes\n      mellitus."
        }, 
        "brief_title": "An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry", 
        "completion_date": {
            "#text": "July 2020", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes Mellitus", 
            "Diabetes Mellitus, Type 1", 
            "Diabetes Mellitus, Type 2"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent obtained before any data collection\n\n          -  Woman with a positive pregnancy test\n\n          -  Diabetes mellitus type 1 or 2, diagnosed prior to conception\n\n          -  Currently treated with Levemir\u00ae or other injectable antidiabetic treatment(s)\n\n          -  Unchanged basal insulin or other injectable antidiabetic treatment product (for those\n             not treated with basal insulin) 4 weeks prior to and following conception\n\n        Exclusion Criteria:\n\n          -  Women who have been pregnant for more than 12 weeks at baseline visit will be\n             excluded from the study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women with diabetes mellitus, who are pregnant and treated with Levemir\u00ae or other\n        injectable antidiabetic treatment regimens, and who have not changed basal insulin or\n        other injectable antidiabetic treatment product (for those not treated with basal insulin)\n        4 weeks prior to and following conception will be included in the Diabetes Pregnancy\n        Registry"
            }
        }, 
        "enrollment": {
            "#text": "3075", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01892319", 
            "org_study_id": "NN304-4016", 
            "secondary_id": [
                "U1111-1132-9442", 
                "ENCEPP/SDPP/4137"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "All patients", 
                "description": "Patients will be treated according to routine clinical practice at the discretion of the treating physician", 
                "intervention_name": "insulin detemir", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "All patients", 
                "description": "Patients will be treated according to routine clinical practice at the discretion of the treating physician", 
                "intervention_name": "other injectable antidiabetic treatment regimens", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Insulin", 
                "Hypoglycemic Agents", 
                "Insulin, Long-Acting"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Zagreb", 
                        "country": "Croatia", 
                        "zip": "10000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarhus N", 
                        "country": "Denmark", 
                        "zip": "8200"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petach Tikva", 
                        "country": "Israel", 
                        "zip": "49100"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "93-338"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41014"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Inverness", 
                        "country": "United Kingdom", 
                        "zip": "IV2 3UJ"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Croatia", 
                "Denmark", 
                "Israel", 
                "Poland", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Levemir\u00ae (Insulin Detemir) in Pregnant Women With Diabetes Mellitus", 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Global Clinical Registry (GCR, 1452)", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Medicines Agency", 
                "France: Ministry of Health", 
                "Israel: Ministry of Health", 
                "Croatia: Ministry of Health and Social Care", 
                "Poland: Ministry of Health", 
                "Spain: Spanish Agency of Medicines", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of pregnancies (Levemir\u00ae treatment), compared to pregnancies (other basal insulin treatment regimens), resulting in none of the following events: Major congenital malformations, Perinatal death, Neonatal death", 
            "safety_issue": "No", 
            "time_frame": "Assessed at up to 4 weeks after delivery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01892319"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of major hypoglycaemia", 
                "safety_issue": "No", 
                "time_frame": "During pregnancy"
            }, 
            {
                "measure": "Proportion of pregnancies complicated by pre-eclampsia", 
                "safety_issue": "No", 
                "time_frame": "During pregnancy"
            }, 
            {
                "measure": "Proportion of pregnancies resulting in perinatal death", 
                "safety_issue": "No", 
                "time_frame": "Assessed 1 week after delivery"
            }, 
            {
                "measure": "Proportion of pregnancies resulting in neonatal death", 
                "safety_issue": "No", 
                "time_frame": "Assessed 4 weeks after delivery"
            }, 
            {
                "measure": "Proportion of pregnancies resulting in spontaneous abortion", 
                "safety_issue": "No", 
                "time_frame": "Assessed at pregnancy termination"
            }, 
            {
                "measure": "Proportion of pregnancies resulting in pre-term delivery", 
                "safety_issue": "No", 
                "time_frame": "Assessed at delivery"
            }, 
            {
                "measure": "Height", 
                "safety_issue": "No", 
                "time_frame": "At the age of 1 year"
            }, 
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "At the age of 1 year"
            }, 
            {
                "measure": "Proportion with changes (progression/regression) of major congenital malformations", 
                "safety_issue": "No", 
                "time_frame": "At the age of 1 year"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}